ResearcherCentral South UniversityNo recent work listed

Ning Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7805-2191; OpenAlex author ID A5069542231. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2014: 1 paper

Papers 1

A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors. Co-author DOI 10.3892/ijo.2014.2350 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Allan H. Conney · 1 shared paper, 2014 · strength 0.04
- Paper A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft … DOI 10.3892/ijo.2014.2350 ↗
Xi Zheng · 1 shared paper, 2014 · strength 0.04
- Paper A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft … DOI 10.3892/ijo.2014.2350 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.